ELEVANCE HEALTH DL-,01/ US0367521038 /
29/08/2024 08:08:14 | Chg. +3.80 | Volume | Bid20:58:37 | Ask20:58:37 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
494.90EUR | +0.77% | 0 Turnover: 0.00 |
497.00Bid Size: 60 | 498.90Ask Size: 60 | 115.11 bill.EUR | - | - |
Assets
2011 US GAAP in mill. USD |
2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Property and Equipment | 1,418.1000 | 1,738.3000 | 1,801.5000 | 1,944.3000 | 2,019.8000 | ||||||
Intangible Assets | 7,931.7000 | 9,102.8000 | 8,441 | 7,958.1000 | 8,158 | ||||||
Long-Term Investments | - | - | - | 2,231.8000 | 2,630.3000 | ||||||
Fixed Assets | - | - | - | 29,836.1000 | 30,855.7000 | ||||||
Inventories | - | - | - | - | - | ||||||
Accounts Receivable | - | - | - | - | 11,943.6000 | ||||||
Cash and Cash Equivalents | 2,201.6000 | 2,484.6000 | 1,582.1000 | 2,151.7000 | 2,113.5000 | ||||||
Current Assets | 27,097.4000 | 28,268.4000 | 29,745.8000 | 32,228.9000 | 30,862.1000 | ||||||
Total Assets | 52,018.8000 | 58,955.4000 | 59,574.5000 | 62,065 | 61,717.8000 |
Liabilities
2011 US GAAP in mill. USD |
2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Accounts Payable | 3,124.1000 | 3,132.5000 | 3,426.3000 | - | 10,888.6000 | ||||||
Long-term debt | - | - | - | 14,127.2000 | 15,324.5000 | ||||||
Liabilities to Banks | 100 | 250 | 400 | 400 | 540 | ||||||
Provisions | 3,454.7000 | 4,131.8000 | 4,048.2000 | 3,897.3000 | 3,262.3000 | ||||||
Liabilities | 28,730.6000 | 35,152.7000 | 34,809.3000 | 37,813.7000 | 38,673.7000 | ||||||
Share Capital | 3.4000 | 3 | 2.9000 | - | 2.6000 | ||||||
Total Equity | 23,288.2000 | 23,802.7000 | 24,765.2000 | 24,251.3000 | 23,044.1000 | ||||||
Minority Interests | 0.0000 | 0.0000 | 0.0000 | - | - | ||||||
Total liabilities equity | 52,018.8000 | 58,955.4000 | 59,574.5000 | 62,065 | 61,717.8000 |
Income Statement
2011 US GAAP in mill. USD |
2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 60,710.7000 | 61,711.7000 | 71,023.5000 | 73,874.1000 | 79,156.5000 | ||||||
Depreciation (total) | 239.4000 | 245.1000 | 245.3000 | 220.9000 | 230.1000 | ||||||
Operating Result | 4,388.2000 | 4,377.3000 | 4,442.9000 | 4,418.4000 | 4,753.1000 | ||||||
Interest Income | -430.3000 | -511.8000 | -602.7000 | 600.7000 | -653 | ||||||
Income Before Taxes | 3,957.9000 | 3,865.5000 | 3,840.2000 | 4,368.1000 | 4,631 | ||||||
Income Taxes | 1,311.2000 | 1,210 | 1,205.9000 | 1,808 | 2,071 | ||||||
Minority Interests Profit | 0.0000 | 0.0000 | 0.0000 | - | - | ||||||
Net Income | 2,646.7000 | 2,655.5000 | 2,489.7000 | 2,569.7000 | 2,560 |
Per Share
Cash Flow
2011 US GAAP in mill. USD |
2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow from Operating Activities | 3,374.4000 | 2,744.6000 | 3,052.3000 | 3,369.3000 | 4,116 | ||||||
Cash Flow from Investing Activities | -942 | -4,551.6000 | -2,234.4000 | -974.9000 | -1,151.5000 | ||||||
Cash Flow from Financing | -2,019.2000 | 2,088.9000 | -1,717.8000 | -1,822.5000 | -2,997.4000 | ||||||
Decrease / Increase in Cash | 412.8000 | 283 | -897.7000 | 564.8000 | -38.2000 | ||||||
Employees | 37,700 | 43,500 | 48,200 | 51,500 | 53,000 |